Mary Kay Inc., through its Mary Kay Ash Foundation, is supporting a groundbreaking initiative that aims to revolutionize early detection and intervention strategies for breast cancer. The foundation’s generous grant is funding the TRIM-EBC Trial (Tirzepatide weight loss in patients with MRD and Early Breast Cancer) in alignment with Baylor Scott & White Health and the Texas Cancer Interception Institute (TCII).

The Mary Kay FoundationSM recently awarded over $3 million in cancer research and domestic violence shelter grants around the country. The Foundation was established in 1996 with the overarching purpose of eliminating cancers affecting women. In 2000, The Foundation expanded to include ending domestic violence as part of its mission. Domestic Violence Shelters A total […]